Stryker Corporation (SYK)

Stryker Corporation (SYK $394.22)
- $394.22 P/E (TTM): 50.97X Cap: $150.71B
- View SYK Profile
- View Questions on SYK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $476.16)
- $476.16 P/E (TTM): 65.44X Cap: $170.69B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $711.68)
- $711.68 P/E (TTM): 57.76X Cap: $673.57B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $394.22)
- $394.22 P/E (TTM): 50.97X Cap: $150.71B
- View SYK Profile
- View Questions on SYK
Novo Nordisk A/S (NVO $56.98)
- $56.98 P/E (TTM): 15.74X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?

Read Answer Asked by David on August 13, 2025

Stryker Corporation (SYK $394.22)
- $394.22 P/E (TTM): 50.97X Cap: $150.71B
- View SYK Profile
- View Questions on SYK

Q: Would you purchase this stock at it's current price for a five year hold?

Read Answer Asked by Brian on August 12, 2025

Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $476.16)
- $476.16 P/E (TTM): 65.44X Cap: $170.69B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
Stryker Corporation (SYK $394.22)
- $394.22 P/E (TTM): 50.97X Cap: $150.71B
- View SYK Profile
- View Questions on SYK
UnitedHealth Group Incorporated (DE) (UNH $307.42)
- $307.42 P/E (TTM): 12.7X Cap: $278.42B
- View UNH Profile
- View Questions on UNH
iShares U.S. Medical Devices ETF (IHI $62.87)
- $62.87 P/E (TTM): 164.7X Cap: $4.41B
- View IHI Profile
- View Questions on IHI

Q: I have been reviewing my health care holdings and I am disappointed in the whole sector. Their percentage of my holdings has dropped, and if I rebalance I should be adding another 50% to these holdings. I am unhappy with IHI and UNH, even ISRG is in the doldrums. Your thoughts on adding to the health care sector and these companies/ETFs at this time. Are there other companies much better suited that I am missing. I am tempted to remove the whole sector from my portfolio, as I am comfortable with risk.

Read Answer Asked by Gordon on August 14, 2025